US Stock MarketDetailed Quotes

NARI Inari Medical

Watchlist
  • 38.180
  • +1.070+2.88%
Close Apr 24 16:00 ET
2.21BMarket Cap-1272666P/E (TTM)

Inari Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
28.73%493.63M
22.57%132.09M
31.35%126.37M
28.32%119.01M
33.91%116.17M
38.45%383.47M
29.50%107.77M
31.94%96.2M
46.16%92.74M
51.14%86.75M
Operating revenue
28.73%493.63M
22.57%132.09M
31.35%126.37M
28.32%119.01M
33.91%116.17M
38.45%383.47M
29.50%107.77M
31.94%96.2M
46.16%92.74M
51.14%86.75M
Cost of revenue
32.72%59.07M
29.54%17.01M
30.85%14.48M
33.80%13.84M
37.86%13.74M
79.77%44.51M
58.55%13.13M
57.16%11.06M
114.94%10.35M
115.60%9.97M
Gross profit
28.20%434.56M
21.60%115.09M
31.42%111.89M
27.63%105.16M
33.39%102.43M
34.39%338.97M
26.30%94.64M
29.24%85.14M
40.52%82.4M
45.50%76.79M
Operating expense
22.21%448.6M
23.72%124.39M
15.63%109.78M
16.29%106.67M
34.93%107.76M
52.07%367.06M
37.36%100.53M
38.39%94.94M
68.22%91.73M
77.24%79.87M
Selling and administrative expenses
23.30%361.06M
26.67%101.49M
16.42%88.28M
16.99%85.59M
34.47%85.7M
53.83%292.84M
47.10%80.12M
35.17%75.83M
70.54%73.16M
72.72%63.73M
Research and development costs
17.94%87.53M
12.15%22.89M
12.49%21.49M
13.55%21.09M
36.75%22.06M
45.48%74.22M
9.00%20.41M
52.85%19.11M
59.66%18.57M
97.66%16.14M
Operating profit
50.06%-14.03M
-57.82%-9.3M
121.57%2.11M
83.81%-1.51M
-73.20%-5.34M
-359.12%-28.1M
-437.40%-5.89M
-259.30%-9.8M
-326.85%-9.33M
-139.96%-3.08M
Net non-operating interest income expense
889.54%15.42M
195.20%2.65M
664.52%4.16M
3,097.16%4.51M
17,947.83%4.11M
1,204.96%1.56M
1,856.86%896K
1,282.61%544K
461.54%141K
-360.00%-23K
Non-operating interest income
743.03%15.61M
179.79%2.71M
579.94%4.2M
2,027.10%4.55M
8,190.00%4.15M
1,102.60%1.85M
3,941.67%970K
2,188.89%618K
511.43%214K
-26.47%50K
Non-operating interest expense
-33.33%196K
-6.76%69K
-41.89%43K
-39.73%44K
-45.21%40K
-0.34%294K
-1.33%74K
1.37%74K
-1.35%73K
0.00%73K
Other net income (expense)
703.65%2.86M
1,759.89%3.48M
-1,055.93%-682K
-89.68%26K
262.50%39K
2,077.78%356K
1,435.71%187K
-296.67%-59K
3,500.00%252K
41.46%-24K
Other non- operating income (expenses)
703.65%2.86M
1,759.89%3.48M
-1,055.93%-682K
-89.68%26K
262.50%39K
2,077.78%356K
1,435.71%187K
-296.67%-59K
3,500.00%252K
41.46%-24K
Income before tax
116.22%4.25M
33.99%-3.17M
160.02%5.59M
133.84%3.02M
61.84%-1.19M
-345.06%-26.19M
-386.02%-4.81M
-239.52%-9.31M
-319.00%-8.94M
-140.81%-3.13M
Income tax
90.85%5.88M
50.61%1.49M
189.05%2.43M
-25.00%939K
1.02M
264.73%3.08M
72.47%990K
1,277.05%840K
10,333.33%1.25M
0
Net income
94.41%-1.64M
19.54%-4.67M
131.14%3.16M
120.47%2.09M
29.11%-2.22M
-397.43%-29.27M
-623.76%-5.8M
-262.09%-10.15M
-350.42%-10.19M
-141.89%-3.13M
Net income continuous Operations
94.41%-1.64M
19.54%-4.67M
131.14%3.16M
120.47%2.09M
29.11%-2.22M
-397.43%-29.27M
-623.76%-5.8M
-262.09%-10.15M
-350.42%-10.19M
-141.89%-3.13M
Minority interest income
Net income attributable to the parent company
94.41%-1.64M
19.54%-4.67M
131.14%3.16M
120.47%2.09M
29.11%-2.22M
-397.43%-29.27M
-623.76%-5.8M
-262.09%-10.15M
-350.42%-10.19M
-141.89%-3.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
94.41%-1.64M
19.54%-4.67M
131.14%3.16M
120.47%2.09M
29.11%-2.22M
-397.43%-29.27M
-623.76%-5.8M
-262.09%-10.15M
-350.42%-10.19M
-141.89%-3.13M
Basic earnings per share
94.55%-0.03
27.27%-0.08
131.58%0.06
121.05%0.04
33.33%-0.04
-375.00%-0.55
-650.00%-0.11
-216.67%-0.19
-337.50%-0.19
-140.00%-0.06
Diluted earnings per share
94.55%-0.03
27.27%-0.08
126.32%0.05
121.05%0.04
33.33%-0.04
-405.56%-0.55
-650.00%-0.11
-216.67%-0.19
-371.43%-0.19
-146.15%-0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 28.73%493.63M22.57%132.09M31.35%126.37M28.32%119.01M33.91%116.17M38.45%383.47M29.50%107.77M31.94%96.2M46.16%92.74M51.14%86.75M
Operating revenue 28.73%493.63M22.57%132.09M31.35%126.37M28.32%119.01M33.91%116.17M38.45%383.47M29.50%107.77M31.94%96.2M46.16%92.74M51.14%86.75M
Cost of revenue 32.72%59.07M29.54%17.01M30.85%14.48M33.80%13.84M37.86%13.74M79.77%44.51M58.55%13.13M57.16%11.06M114.94%10.35M115.60%9.97M
Gross profit 28.20%434.56M21.60%115.09M31.42%111.89M27.63%105.16M33.39%102.43M34.39%338.97M26.30%94.64M29.24%85.14M40.52%82.4M45.50%76.79M
Operating expense 22.21%448.6M23.72%124.39M15.63%109.78M16.29%106.67M34.93%107.76M52.07%367.06M37.36%100.53M38.39%94.94M68.22%91.73M77.24%79.87M
Selling and administrative expenses 23.30%361.06M26.67%101.49M16.42%88.28M16.99%85.59M34.47%85.7M53.83%292.84M47.10%80.12M35.17%75.83M70.54%73.16M72.72%63.73M
Research and development costs 17.94%87.53M12.15%22.89M12.49%21.49M13.55%21.09M36.75%22.06M45.48%74.22M9.00%20.41M52.85%19.11M59.66%18.57M97.66%16.14M
Operating profit 50.06%-14.03M-57.82%-9.3M121.57%2.11M83.81%-1.51M-73.20%-5.34M-359.12%-28.1M-437.40%-5.89M-259.30%-9.8M-326.85%-9.33M-139.96%-3.08M
Net non-operating interest income expense 889.54%15.42M195.20%2.65M664.52%4.16M3,097.16%4.51M17,947.83%4.11M1,204.96%1.56M1,856.86%896K1,282.61%544K461.54%141K-360.00%-23K
Non-operating interest income 743.03%15.61M179.79%2.71M579.94%4.2M2,027.10%4.55M8,190.00%4.15M1,102.60%1.85M3,941.67%970K2,188.89%618K511.43%214K-26.47%50K
Non-operating interest expense -33.33%196K-6.76%69K-41.89%43K-39.73%44K-45.21%40K-0.34%294K-1.33%74K1.37%74K-1.35%73K0.00%73K
Other net income (expense) 703.65%2.86M1,759.89%3.48M-1,055.93%-682K-89.68%26K262.50%39K2,077.78%356K1,435.71%187K-296.67%-59K3,500.00%252K41.46%-24K
Other non- operating income (expenses) 703.65%2.86M1,759.89%3.48M-1,055.93%-682K-89.68%26K262.50%39K2,077.78%356K1,435.71%187K-296.67%-59K3,500.00%252K41.46%-24K
Income before tax 116.22%4.25M33.99%-3.17M160.02%5.59M133.84%3.02M61.84%-1.19M-345.06%-26.19M-386.02%-4.81M-239.52%-9.31M-319.00%-8.94M-140.81%-3.13M
Income tax 90.85%5.88M50.61%1.49M189.05%2.43M-25.00%939K1.02M264.73%3.08M72.47%990K1,277.05%840K10,333.33%1.25M0
Net income 94.41%-1.64M19.54%-4.67M131.14%3.16M120.47%2.09M29.11%-2.22M-397.43%-29.27M-623.76%-5.8M-262.09%-10.15M-350.42%-10.19M-141.89%-3.13M
Net income continuous Operations 94.41%-1.64M19.54%-4.67M131.14%3.16M120.47%2.09M29.11%-2.22M-397.43%-29.27M-623.76%-5.8M-262.09%-10.15M-350.42%-10.19M-141.89%-3.13M
Minority interest income
Net income attributable to the parent company 94.41%-1.64M19.54%-4.67M131.14%3.16M120.47%2.09M29.11%-2.22M-397.43%-29.27M-623.76%-5.8M-262.09%-10.15M-350.42%-10.19M-141.89%-3.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 94.41%-1.64M19.54%-4.67M131.14%3.16M120.47%2.09M29.11%-2.22M-397.43%-29.27M-623.76%-5.8M-262.09%-10.15M-350.42%-10.19M-141.89%-3.13M
Basic earnings per share 94.55%-0.0327.27%-0.08131.58%0.06121.05%0.0433.33%-0.04-375.00%-0.55-650.00%-0.11-216.67%-0.19-337.50%-0.19-140.00%-0.06
Diluted earnings per share 94.55%-0.0327.27%-0.08126.32%0.05121.05%0.0433.33%-0.04-405.56%-0.55-650.00%-0.11-216.67%-0.19-371.43%-0.19-146.15%-0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg